영상 서비스 시장 : 서비스 유형별, 모달리티별, 용도별, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Imaging Services Market is projected to grow by USD 193.78 billion at a CAGR of 6.14% by 2032.

Medical imaging services sit at the center of modern diagnosis, treatment planning, screening, and follow-up care. Demand is being reinforced by structural healthcare trends: the World Health Organization reports that noncommunicable diseases account for 74% of global deaths, while the International Agency for Research on Cancer estimated about 20 million new cancer cases in 2022 and projects a substantial rise by 2050. These disease burdens directly increase utilization of MRI, CT, ultrasound, X-ray, mammography, fluoroscopy, nuclear medicine, and PET imaging across acute, ambulatory, and preventive care pathways.

For healthcare providers and imaging center operators, the market is shifting from modality-led growth to service-led differentiation. Capacity, turnaround time, subspecialty reporting, patient experience, radiation safety, interoperability, and value-based clinical pathways are now decisive competitive factors. Imaging services that connect radiology workflows with electronic health records, oncology programs, cardiology networks, emergency departments, and ambulatory care settings are better positioned to improve diagnostic access while controlling total cost of care.

Transformative Shifts in the Imaging Services Landscape

The imaging services landscape is being reshaped by the migration of care from hospitals to outpatient and ambulatory settings, rising use of preventive screening, and the need for faster emergency and oncology diagnostics. Health systems are increasingly consolidating radiology operations across enterprise networks to standardize protocols, optimize scanner utilization, improve referral management, and reduce variability in reporting quality.

Digital transformation is equally important. PACS, RIS, vendor-neutral archives, cloud-enabled image exchange, and structured reporting are becoming essential for scalable radiology services. Teleradiology has moved from after-hours coverage to a strategic operating model that supports subspecialty access, workload balancing, continuity of care, and rural healthcare coverage across regions facing radiologist shortages.

Cumulative Impact of Artificial Intelligence on Imaging Services

Artificial intelligence is having a cumulative impact across imaging acquisition, triage, interpretation support, reporting, and operational orchestration. The U.S. FDA's public database of AI/ML-enabled medical devices shows radiology as the largest category of authorized AI-enabled devices, reflecting the maturity of imaging data, the availability of standardized DICOM workflows, and the clinical need for faster detection and prioritization.

For providers, the near-term value of AI is strongest where it reduces bottlenecks rather than replaces clinicians. Evidence-backed use cases include worklist triage for time-sensitive findings, automated measurements, image quality enhancement, dose optimization, and structured report assistance. Responsible adoption requires local validation, bias monitoring, cybersecurity controls, clinician oversight, and alignment with regulatory frameworks such as FDA software oversight, EU Medical Device Regulation requirements, and institutional governance for clinical AI.

Key Regional Insights: Imaging Services Demand Across Major Regions

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN health systems invest in hospital capacity, cancer care, and digital health infrastructure. Japan and South Korea are characterized by advanced equipment penetration and aging populations, while India and Southeast Asia show strong demand for affordable diagnostic imaging access in tier-2 and tier-3 cities. China's hospital modernization programs and expanding oncology services continue to support broader deployment of CT, MRI, ultrasound, and nuclear medicine capabilities.

North America remains a high-value imaging services region due to established reimbursement systems, extensive outpatient imaging networks, high adoption of advanced modalities, and strong AI regulatory activity. Europe is shaped by public healthcare systems, EU-level data protection requirements, cancer screening programs, and modernization of diagnostic capacity. Latin America is driven by private provider expansion and uneven access between urban and rural areas, with Brazil and Mexico serving as important diagnostic imaging hubs. The Middle East, led by GCC investment in specialty hospitals, health system transformation, and medical tourism, is upgrading advanced imaging capability, whereas Africa continues to prioritize access, workforce development, mobile imaging, and public-private partnerships to address diagnostic gaps.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is becoming an important imaging services corridor as governments expand universal health coverage and private hospital groups invest in radiology networks, particularly in Indonesia, Thailand, Vietnam, Malaysia, and the Philippines. GCC countries are prioritizing advanced diagnostic imaging as part of healthcare transformation programs, with demand linked to oncology, cardiology, trauma, preventive health, and medical tourism.

The European Union is focused on harmonized quality, data protection, cross-border health data exchange, and compliance with medical device and AI regulations. BRICS economies represent a large-volume opportunity because of population scale, noncommunicable disease growth, and infrastructure expansion, although reimbursement and access vary widely. G7 markets concentrate premium demand for advanced MRI, CT, PET, interventional imaging, and AI-enabled workflow tools, while NATO countries increasingly recognize medical imaging as part of resilient health infrastructure for civilian care, emergency preparedness, and defense medical readiness.

Key Country Insights: Priority Imaging Services Markets

The United States leads in outpatient imaging networks, AI-enabled radiology adoption, advanced modality utilization, and value-based diagnostic pathways, while Canada emphasizes equitable access, wait-time reduction, and modernization of public diagnostic capacity. Mexico and Brazil are expanding private imaging networks, with Brazil serving as a major Latin American hub for advanced diagnostics and Mexico benefiting from urban private hospital growth and cross-border care dynamics.

In Europe, the United Kingdom is focused on diagnostic center expansion and public system capacity improvement; Germany and France maintain strong hospital-based imaging ecosystems supported by specialty care networks; Italy and Spain are upgrading equipment and digital infrastructure; and Russia continues to rely on large public-sector diagnostic networks. In Asia-Pacific, China is scaling imaging access across hospital tiers, India is expanding affordable diagnostics and teleradiology, Japan is driven by aging-related imaging demand, Australia emphasizes quality and geographic access, and South Korea combines advanced hospitals with strong digital health capabilities and high technology readiness.

Actionable Recommendations for Imaging Services Leaders

Industry leaders should prioritize enterprise imaging strategies that connect radiology, cardiology, oncology, emergency care, and outpatient diagnostics through interoperable platforms. Investment should focus on scanner uptime, protocol standardization, dose management, structured reporting, cybersecurity, image exchange, and patient scheduling tools that reduce no-shows and improve throughput.

Providers should adopt AI through clinically governed pilots tied to measurable outcomes such as report turnaround time, critical finding notification, recall reduction, scanner productivity, and patient safety. Partnerships with payers, referring physicians, and technology vendors should be structured around value-based metrics, including earlier diagnosis, reduced duplication of imaging, lower downstream costs, stronger care coordination, and better patient satisfaction.

Research Methodology: Evidence-Based Imaging Services Assessment

This executive summary is built from secondary research using public and verifiable sources, including health agency publications, regulatory databases, national health system updates, peer-reviewed clinical literature, and industry disclosures related to imaging infrastructure, AI-enabled medical devices, and diagnostic service delivery.

The methodology combines demand-side assessment of disease burden, aging, screening needs, and care setting shifts with supply-side analysis of modality capacity, workforce availability, interoperability, reimbursement, and regulatory readiness. Regional, group, and country insights were synthesized through comparative evaluation of healthcare infrastructure maturity, digital health adoption, public-private investment, quality standards, and access constraints.

Conclusion: Connected, AI-Ready Imaging Services Will Define Growth

Imaging services are evolving from diagnostic support functions into strategic clinical platforms that influence patient pathways, population health, and healthcare economics. The strongest providers will be those that combine advanced modalities with scalable workflow, subspecialty expertise, AI governance, radiation safety, and patient-centered access.

Across mature and emerging markets, the core opportunity is consistent: deliver faster, safer, more connected, and more affordable diagnostic imaging. Organizations that modernize enterprise imaging infrastructure and align operations with measurable clinical outcomes will be best positioned for sustainable growth.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Imaging Services Market, by Service Type

• 7.1. Computed Tomography (CT) Imaging
• 7.2. Magnetic Resonance Imaging (MRI)
  • 7.2.1. Functional MRI
  • 7.2.2. Open MRI
• 7.3. Nuclear Imaging
• 7.4. Ultrasound Imaging
• 7.5. X-ray Imaging
  • 7.5.1. Computed Radiography (CR)
  • 7.5.2. Digital Radiography (DR)

8. Imaging Services Market, by Modality

• 8.1. Hybrid Imaging Systems
• 8.2. Portable Imaging Systems
• 8.3. Standalone Imaging Systems

9. Imaging Services Market, by Application

• 9.1. Cardiology Imaging
• 9.2. Gastrointestinal Imaging
• 9.3. Neurology Imaging
• 9.4. Oncology Imaging
• 9.5. Orthopedic & Musculoskeletal Imaging
• 9.6. Urology Imaging

10. Imaging Services Market, by End-User

• 10.1. Ambulatory Surgical Centers
• 10.2. Diagnostic Centers
• 10.3. Hospitals & Clinics
• 10.4. Research & Academic Institutions

11. Imaging Services Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Imaging Services Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Imaging Services Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Alliance HealthCare Services, Inc.
• 15.2. Analogic Corporation
• 15.3. Apex Radiology
• 15.4. Banner Health
• 15.5. Bracco Imaging S.p.A.
• 15.6. Bruker Corporation
• 15.7. Butterfly Network
• 15.8. Capitol Imaging Services
• 15.9. Carestream Health, Inc
• 15.10. Esaote S.p.A.
• 15.11. Fujifilm Holdings Corporation
• 15.12. GE Healthcare
• 15.13. Global Diagnostics Imaging
• 15.14. Healius Limited
• 15.15. I-MED Radiology Network
• 15.16. iCAD, Inc.
• 15.17. Konica Minolta, Inc.
• 15.18. MXR Imaging Inc.
• 15.19. PerkinElmer, Inc.
• 15.20. Radnet, Inc.
• 15.21. RAYUS Radiology
• 15.22. Siemens AG
• 15.23. Simonmed Imaging
• 15.24. Sonic Healthcare Limited
• 15.25. Unilabs AB
• 15.26. Ziehm Imaging GmbH